Genpharmasec (BOM:531592) Total Liabilities : ₹0.0 Mil (As of Dec. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Genpharmasec Total Liabilities?

Genpharmasec's Total Liabilities for the quarter that ended in Dec. 2024 was ₹0.0 Mil.

Genpharmasec's quarterly Total Liabilities increased from Jun. 2024 (₹0.00 Mil) to Sep. 2024 (₹98.72 Mil) but then declined from Sep. 2024 (₹98.72 Mil) to Dec. 2024 (₹0.00 Mil).

Genpharmasec's annual Total Liabilities declined from Mar. 2022 (₹62.81 Mil) to Mar. 2023 (₹45.35 Mil) but then increased from Mar. 2023 (₹45.35 Mil) to Mar. 2024 (₹65.91 Mil).

Genpharmasec Total Liabilities Historical Data

The historical data trend for Genpharmasec's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genpharmasec Total Liabilities Chart

Genpharmasec Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Liabilities

Get a 7-Day Free Trial

57.23

71.58

62.81

45.35

65.91

Genpharmasec Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															-	65.91	-	98.72	-

Genpharmasec Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Genpharmasec's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	27.02	+	(38.887	+	0.0010000000000048
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	65.9

Total Liabilities	=	Total Assets (A: Mar. 2024 )	-	Total Equity (A: Mar. 2024 )
	=	711.256	-	645.348
	=	65.9

Genpharmasec's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	N/A

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	N/A	-	N/A
	=	N/A

Genpharmasec Total Liabilities Related Terms

Thank you for viewing the detailed overview of Genpharmasec's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Genpharmasec Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genpharmasec Ltd (BOM:531592) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

Akurli Road, Office No. 104 and 105, 1st Floor, Gundecha Industrial Premises Co-op Soc. Ltd., Kandivali (East), Mumbai, MH, IND, 400101

Website

https://www.genpharmasec.com

Genpharmasec Ltd is engaged in pharmaceutical activities and services. The company operates in two reportable segments namely; Diagnostic Pharma Equipment which includes pharmaceutical, medicinal, and medicated preparations, patent medicines, drugs, and herbs, and pharmaceutical, medicinal, and proprietary and industrial preparations, compounds, and articles of kinds, chemists, druggists, and chemical manufacturers. The Trading in the Securities segment of the company invests in the secondary securities market. The Diagnostic Pharma Equipment segment is the key revenue generator for the group.

Genpharmasec Headlines

No Headlines